Regulatory Notice 8 Jan 2025 healthcare, public comment, data collection, cdc, cancer registry

🏥Proposed Data Collection Notice by CDC on Cancer Registry

The Centers for Disease Control and Prevention (CDC), as part of its continuing effort to reduce public burden and maximize the utility of government information, invites the general public and other federal agencies the opportunity to comment on a continuing information collection, as required by the Paperwork Reduction Act of 1995. This notice invites comment on a proposed information collection project titled National Program of Cancer Registries Cancer Surveillance System. This information collection creates a Cancer Registry that provides useful data on cancer incidence, trends, and outcomes.

Learn More
Compliance, Regulatory Requirements 8 Jan 2025 compliance, consumer protection, business and industry, electronic filing, imports, administrative practice and procedure, reporting and recordkeeping requirements, business operations, import regulations, labeling, efiling, agency for international development, cpcs, consumer products

📜CPSC Final Rule on Electronic Filing of Compliance Certificates

In consultation with U.S. Customs and Border Protection (CBP), the U.S. Consumer Product Safety Commission (Commission or CPSC) issues this final rule (the Final Rule) to revise the agency's regulation for Certificates of Compliance (certificates). The Final Rule aligns CPSC's current certificates rule with other CPSC rules on testing and certification, and implements, for importation of products and substances regulated by CPSC, electronic filing of certificates (eFiling) with CBP.

Learn More
Regulatory Changes, Financial Assistance 8 Jan 2025 compliance, regulation, small business, investment, financial services
Regulatory Update 8 Jan 2025 information collection, housing, urban development, indian tribes, alaska native villages

🏢HUD Notice

HUD is publishing this notice to correct the heading on the notice that was published in the Federal Register on December 26, 2024. The heading should read 30-day Notice of Proposed Information Collection.

Learn More
Compliance, Regulatory Requirements 8 Jan 2025 compliance, regulation, aviation, faa, incorporation by reference, navigation (air), airports, airport, air traffic control

✈️FAA Final Rule on Instrument Approach Procedures Effective January 2025

This rule amends, suspends, or removes Standard Instrument Approach Procedures (SIAPs) and associated Takeoff Minimums and Obstacle Departure Procedures for operations at certain airports. These regulatory actions are needed because of the adoption of new or revised criteria, or because of changes occurring in the National Airspace System, such as the commissioning of new navigational facilities, adding new obstacles, or changing air traffic requirements. These changes are designed to provide for the safe and efficient use of the navigable airspace and to promote safe flight operations under instrument flight rules at the affected airports.

Learn More
Regulatory Compliance, Funding Opportunities, Employment Initiatives 8 Jan 2025 regulatory compliance, indian health service, funding agreements, tribal health, reorganization, health policy

🏥Regulatory Changes in Indian Health Service Impacting Businesses

Part G of the Statement of Organization, Functions, and Delegations of Authority of the Department of Health and Human Services (HHS) is hereby amended to reflect a reorganization of the Indian Health Service (IHS). The purpose of this reorganization is to revise the current approved structure for the IHS, Office of the Director, Intergovernmental Affairs functions in Chapter GA (GAA-GAC), as provided for herein.

Learn More
Compliance, Financial Regulation 8 Jan 2025 compliance, energy, regulatory filings, market power, ferc, financial analysis
Compliance, Regulatory Requirements 8 Jan 2025 compliance, regulation, fda, debarment, fdca, drug importation, businesses

🚫FDA Denies Hearing; Jiao Debarred for Five Years from Drug Imports

The Food and Drug Administration (FDA or Agency) is denying a request for a hearing submitted by Yong Sheng Jiao, also known as Yongsheng Jiao and Wilson Jiao (Jiao), and is issuing an order under the Federal Food, Drug, and Cosmetic Act (FD&C Act) debarring Jiao for 5 years from importing or offering for import any drug into the United States. FDA bases this order on a finding that Jiao was convicted of a felony under Federal law for conduct relating to the importation into the United States of any drug or controlled substance under the FD&C Act. In determining the appropriateness and period of Jiao's debarment, FDA considered the relevant factors listed in the FD&C Act. Jiao submitted a request for hearing but failed to file with the Agency information and analyses sufficient to create a basis for a hearing.

Learn More
Compliance, Regulatory 8 Jan 2025 healthcare, fda, drug development, clinical trials, optical imaging

🩺FDA Draft Guidance on Developing Drugs for Optical Imaging

The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft guidance for industry entitled "Developing Drugs for Optical Imaging." The purpose of this guidance is to provide recommendations to sponsors regarding clinical trial design features that support development and approval of optical imaging drugs that are used in conjunction with imaging devices and intended as intraoperative aids for the detection of pathology such as tumors or to enhance the conspicuity of normal anatomical structures.

Learn More
Financial Assistance, Regulatory Changes 8 Jan 2025 agriculture, usda, financial assistance, funding opportunities, specialty crops

🌾USDA Extends Marketing Assistance for Specialty Crops Applications

The Farm Service Agency (FSA) is announcing changes to the available funding, payment limitation, and application deadline for Marketing Assistance for Specialty Crops (MASC).

Learn More